Resource Centers

View More Biosimilars Blood Cancer Covid-19 Dermatology Digital Health Eye Care Hemophilia HIV Liver Disease Lung Cancer Multiple Sclerosis Neonatal Care Post-Acute Care Prescription Digital Therapeutics Sleep Disorders Ulcerative Colitis Vaccines

Biosimilars Blood Cancer Covid-19 Dermatology Digital Health Eye Care Hemophilia HIV Liver Disease Lung Cancer Multiple Sclerosis Neonatal Care Post-Acute Care Prescription Digital Therapeutics Sleep Disorders Ulcerative Colitis Vaccines

AMCP Annual Asembia’s 2022 Specialty Pharmacy Summit AMCP Nexus K-Cast PBMI National Conference Population Health Perspectives Updates in Vaccine Management

AMCP Annual Asembia’s 2022 Specialty Pharmacy Summit AMCP Nexus K-Cast PBMI National Conference Population Health Perspectives Updates in Vaccine Management

View More Business Strategy Chronic Disease Consumers Drug Costs Drug Pipeline Formulary Health Management Health/Disease Strategy Hospitals & Providers Industry Analysis Pharmacy Politics and Policy Practice Management Reimbursement Technology

Business Strategy Chronic Disease Consumers Drug Costs Drug Pipeline Formulary Health Management Health/Disease Strategy Hospitals & Providers Industry Analysis Pharmacy Politics and Policy Practice Management Reimbursement Technology

Expert Interviews

Medical World News

Population Health Perspectives

Expert Interviews K-Cast Medical World News Podcasts Population Health Perspectives

Conferences Partners

MHE Publication

Supplements And Featured Publications

MHE Publication Supplements And Featured Publications

Sponsored Content

PBM Leaders Sponsored Sponsored Content Surveys

Print Subscription

eNewsletter Print Subscription

About Us
Advertise
Editorial
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Informations

© 2023 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advertisement

Resource CentersSee All >

Biosimilars
Blood Cancer
Covid-19
Dermatology
Digital Health
Eye Care
Hemophilia
HIV
Liver Disease
Lung Cancer
Multiple Sclerosis
Neonatal Care
Post-Acute Care
Prescription Digital Therapeutics
Sleep Disorders
Ulcerative Colitis
Vaccines

Spotlight

AMCP Annual
Asembia’s 2022 Specialty Pharmacy Summit
AMCP Nexus
K-Cast
PBMI National Conference
Population Health Perspectives
Updates in Vaccine Management

BusinessSee All >

Business Strategy
Chronic Disease
Consumers
Drug Costs
Drug Pipeline
Formulary
Health Management
Health/Disease Strategy
Hospitals & Providers
Industry Analysis
Pharmacy
Politics and Policy
Practice Management
Reimbursement
Technology

About Us
Advertise
Editorial
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Informations

© 2023 MJH Life Sciences^™ and Managed Healthcare Executive. All rights reserved.

FDA OK with switching drugs to OTC

June 1, 2003

FDA officials are interested in encouraging more OTC switches

Advertisement

Advertisement